Immutable evidence record · ticker
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378)
Published as observed on 21 August 2026 at 16:17 BST.
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. has a balanced company news read. Its latest completed weekly trend is positive.
- As of
- 21 Aug 2026, 16:17
- Scope
- company and instrument
- Evidence
- 3 items
- Independent sources
- 1
- Country
- Hong Kong
- Sector
- Healthcare
- Previous read
- 50.000
- Change
- 1.000
Verification
Evidence & related research
Company chart →Technicals & Market Dynamics →Technical Research Pack →Company news sentiment →Current financial news →
This is dated market research. Coverage may be delayed, incomplete or unavailable.
Cite this record:
Sharemaestro, Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (3378), 2026-08-21, https://sharemaestro.com/evidence/b2e5b1f3-de09-4fba-b2f8-17ede17ab346/
Record checksum f2966fa5e8dc21c16fbd6b638787a99a1dced2c4dcc6939a7e1eaa2d283cd423
